The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Human Rabies Vaccines Market Research Report 2024

Global Human Rabies Vaccines Market Research Report 2024

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1415247

No of Pages : 88

Ask Your Query

Synopsis

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus. 

There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.

Global Human Rabies Vaccines market is projected to reach US$ 1352.3 million in 2029, increasing from US$ 1056 million in 2022, with the CAGR of 3.5% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Rabies Vaccines market research.

Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.

Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.

The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.

Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Human Rabies Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  •     Sanofi Pasteur，Inc.
  •     Novartis Vaccines and Diagnostics Ltd.
  •     Cadila Pharmaceuticals Ltd.
  •     GlaxoSmithKline Biologicals
  •     Merck＆Co Inc.
  •     Wyeth pharmaceuticals
  •     Berna Biotech Ltd.
  •     Medimmune LLC

Segment by Type

  •     Vero Cell Rabies Vaccine
  •     BHK
  •     Chick Embryo Cell Rabies Vaccine
  •     Others

Segment by Application

  •     Pre-Exposure Prophylaxis
  •     Post-Exposure Prophylaxis

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

The Human Rabies Vaccines report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source

Index

 1.1 Product Overview and Scope of Human Rabies Vaccines
    1.2 Human Rabies Vaccines Segment by Type
        1.2.1 Global Human Rabies Vaccines Market Value Comparison by Type (2023-2029)
        1.2.2 Vero Cell Rabies Vaccine
        1.2.3 BHK
        1.2.4 Chick Embryo Cell Rabies Vaccine
        1.2.5 Others
    1.3 Human Rabies Vaccines Segment by Application
        1.3.1 Global Human Rabies Vaccines Market Value by Application: (2023-2029)
        1.3.2 Pre-Exposure Prophylaxis
        1.3.3 Post-Exposure Prophylaxis
    1.4 Global Human Rabies Vaccines Market Size Estimates and Forecasts
        1.4.1 Global Human Rabies Vaccines Revenue 2018-2029
        1.4.2 Global Human Rabies Vaccines Sales 2018-2029
        1.4.3 Global Human Rabies Vaccines Market Average Price (2018-2029)
    1.5 Assumptions and Limitations

 2 Human Rabies Vaccines Market Competition by Manufacturers
    2.1 Global Human Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
    2.2 Global Human Rabies Vaccines Revenue Market Share by Manufacturers (2018-2023)
    2.3 Global Human Rabies Vaccines Average Price by Manufacturers (2018-2023)
    2.4 Global Human Rabies Vaccines Industry Ranking 2021 VS 2022 VS 2023
    2.5 Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Sites & Headquarters
    2.6 Global Key Manufacturers of Human Rabies Vaccines, Product Type & Application
    2.7 Human Rabies Vaccines Market Competitive Situation and Trends
        2.7.1 Human Rabies Vaccines Market Concentration Rate
        2.7.2 The Global Top 5 and Top 10 Largest Human Rabies Vaccines Players Market Share by Revenue
        2.7.3 Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

 3 Human Rabies Vaccines Retrospective Market Scenario by Region
    3.1 Global Human Rabies Vaccines Market Size by Region: 2018 Versus 2022 Versus 2029
    3.2 Global Human Rabies Vaccines Global Human Rabies Vaccines Sales by Region: 2018-2029
        3.2.1 Global Human Rabies Vaccines Sales by Region: 2018-2023
        3.2.2 Global Human Rabies Vaccines Sales by Region: 2024-2029
    3.3 Global Human Rabies Vaccines Global Human Rabies Vaccines Revenue by Region: 2018-2029
        3.3.1 Global Human Rabies Vaccines Revenue by Region: 2018-2023
        3.3.2 Global Human Rabies Vaccines Revenue by Region: 2024-2029
    3.4 North America Human Rabies Vaccines Market Facts & Figures by Country
        3.4.1 North America Human Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.4.2 North America Human Rabies Vaccines Sales by Country (2018-2029)
        3.4.3 North America Human Rabies Vaccines Revenue by Country (2018-2029)
        3.4.4 U.S.
        3.4.5 Canada
    3.5 Europe Human Rabies Vaccines Market Facts & Figures by Country
        3.5.1 Europe Human Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.5.2 Europe Human Rabies Vaccines Sales by Country (2018-2029)
        3.5.3 Europe Human Rabies Vaccines Revenue by Country (2018-2029)
        3.5.4 Germany
        3.5.5 France
        3.5.6 U.K.
        3.5.7 Italy
        3.5.8 Russia
    3.6 Asia Pacific Human Rabies Vaccines Market Facts & Figures by Country
        3.6.1 Asia Pacific Human Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.6.2 Asia Pacific Human Rabies Vaccines Sales by Country (2018-2029)
        3.6.3 Asia Pacific Human Rabies Vaccines Revenue by Country (2018-2029)
        3.6.4 China
        3.6.5 Japan
        3.6.6 South Korea
        3.6.7 India
        3.6.8 Australia
        3.6.9 Taiwan
        3.6.10 Indonesia
        3.6.11 Thailand
        3.6.12 Malaysia
        3.6.13 Philippines
    3.7 Latin America Human Rabies Vaccines Market Facts & Figures by Country
        3.7.1 Latin America Human Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.7.2 Latin America Human Rabies Vaccines Sales by Country (2018-2029)
        3.7.3 Latin America Human Rabies Vaccines Revenue by Country (2018-2029)
        3.7.4 Mexico
        3.7.5 Brazil
        3.7.6 Argentina
    3.8 Middle East and Africa Human Rabies Vaccines Market Facts & Figures by Country
        3.8.1 Middle East and Africa Human Rabies Vaccines Market Size by Country: 2018 VS 2022 VS 2029
        3.8.2 Middle East and Africa Human Rabies Vaccines Sales by Country (2018-2029)
        3.8.3 Middle East and Africa Human Rabies Vaccines Revenue by Country (2018-2029)
        3.8.4 Turkey
        3.8.5 Saudi Arabia
        3.8.6 U.A.E

 4 Segment by Type
    4.1 Global Human Rabies Vaccines Sales by Type (2018-2029)
        4.1.1 Global Human Rabies Vaccines Sales by Type (2018-2023)
        4.1.2 Global Human Rabies Vaccines Sales by Type (2024-2029)
        4.1.3 Global Human Rabies Vaccines Sales Market Share by Type (2018-2029)
    4.2 Global Human Rabies Vaccines Revenue by Type (2018-2029)
        4.2.1 Global Human Rabies Vaccines Revenue by Type (2018-2023)
        4.2.2 Global Human Rabies Vaccines Revenue by Type (2024-2029)
        4.2.3 Global Human Rabies Vaccines Revenue Market Share by Type (2018-2029)
    4.3 Global Human Rabies Vaccines Price by Type (2018-2029)

 5 Segment by Application
    5.1 Global Human Rabies Vaccines Sales by Application (2018-2029)
        5.1.1 Global Human Rabies Vaccines Sales by Application (2018-2023)
        5.1.2 Global Human Rabies Vaccines Sales by Application (2024-2029)
        5.1.3 Global Human Rabies Vaccines Sales Market Share by Application (2018-2029)
    5.2 Global Human Rabies Vaccines Revenue by Application (2018-2029)
        5.2.1 Global Human Rabies Vaccines Revenue by Application (2018-2023)
        5.2.2 Global Human Rabies Vaccines Revenue by Application (2024-2029)
        5.2.3 Global Human Rabies Vaccines Revenue Market Share by Application (2018-2029)
    5.3 Global Human Rabies Vaccines Price by Application (2018-2029)

 6 Key Companies Profiled
    6.1 Sanofi Pasteur，Inc.
        6.1.1 Sanofi Pasteur，Inc. Corporation Information
        6.1.2 Sanofi Pasteur，Inc. Description and Business Overview
        6.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.1.4 Sanofi Pasteur，Inc. Human Rabies Vaccines Product Portfolio
        6.1.5 Sanofi Pasteur，Inc. Recent Developments/Updates
    6.2 Novartis Vaccines and Diagnostics Ltd.
        6.2.1 Novartis Vaccines and Diagnostics Ltd. Corporation Information
        6.2.2 Novartis Vaccines and Diagnostics Ltd. Description and Business Overview
        6.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Portfolio
        6.2.5 Novartis Vaccines and Diagnostics Ltd. Recent Developments/Updates
    6.3 Cadila Pharmaceuticals Ltd.
        6.3.1 Cadila Pharmaceuticals Ltd. Corporation Information
        6.3.2 Cadila Pharmaceuticals Ltd. Description and Business Overview
        6.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Portfolio
        6.3.5 Cadila Pharmaceuticals Ltd. Recent Developments/Updates
    6.4 GlaxoSmithKline Biologicals
        6.4.1 GlaxoSmithKline Biologicals Corporation Information
        6.4.2 GlaxoSmithKline Biologicals Description and Business Overview
        6.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Product Portfolio
        6.4.5 GlaxoSmithKline Biologicals Recent Developments/Updates
    6.5 Merck＆Co Inc.
        6.5.1 Merck＆Co Inc. Corporation Information
        6.5.2 Merck＆Co Inc. Description and Business Overview
        6.5.3 Merck＆Co Inc. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.5.4 Merck＆Co Inc. Human Rabies Vaccines Product Portfolio
        6.5.5 Merck＆Co Inc. Recent Developments/Updates
    6.6 Wyeth pharmaceuticals
        6.6.1 Wyeth pharmaceuticals Corporation Information
        6.6.2 Wyeth pharmaceuticals Description and Business Overview
        6.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Product Portfolio
        6.6.5 Wyeth pharmaceuticals Recent Developments/Updates
    6.7 Berna Biotech Ltd.
        6.6.1 Berna Biotech Ltd. Corporation Information
        6.6.2 Berna Biotech Ltd. Description and Business Overview
        6.6.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.4.4 Berna Biotech Ltd. Human Rabies Vaccines Product Portfolio
        6.7.5 Berna Biotech Ltd. Recent Developments/Updates
    6.8 Medimmune LLC
        6.8.1 Medimmune LLC Corporation Information
        6.8.2 Medimmune LLC Description and Business Overview
        6.8.3 Medimmune LLC Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
        6.8.4 Medimmune LLC Human Rabies Vaccines Product Portfolio
        6.8.5 Medimmune LLC Recent Developments/Updates

 7 Industry Chain and Sales Channels Analysis
    7.1 Human Rabies Vaccines Industry Chain Analysis
    7.2 Human Rabies Vaccines Key Raw Materials
        7.2.1 Key Raw Materials
        7.2.2 Raw Materials Key Suppliers
    7.3 Human Rabies Vaccines Production Mode & Process
    7.4 Human Rabies Vaccines Sales and Marketing
        7.4.1 Human Rabies Vaccines Sales Channels
        7.4.2 Human Rabies Vaccines Distributors
    7.5 Human Rabies Vaccines Customers

 8 Human Rabies Vaccines Market Dynamics
    8.1 Human Rabies Vaccines Industry Trends
    8.2 Human Rabies Vaccines Market Drivers
    8.3 Human Rabies Vaccines Market Challenges
    8.4 Human Rabies Vaccines Market Restraints

 9 Research Finding and Conclusion

 10 Methodology and Data Source
    10.1 Methodology/Research Approach
        10.1.1 Research Programs/Design
        10.1.2 Market Size Estimation
        10.1.3 Market Breakdown and Data Triangulation
    10.2 Data Source
        10.2.1 Secondary Sources
        10.2.2 Primary Sources
    10.3 Author List
    10.4 Disclaimer

 

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock